IP Verse

Reprogramming Immortalized B Cells - EP2601289

The patent EP2601289 was granted to Cellular Dynamics on Jul 12, 2017. The application was originally filed on Aug 3, 2011 under application number EP11815273A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2601289

CELLULAR DYNAMICS
Application Number
EP11815273A
Filing Date
Aug 3, 2011
Status
Opposition Rejected
Feb 7, 2020
Grant Date
Jul 12, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREApr 12, 2018GREGSONADMISSIBLE

Patent Citations (65) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1507865
DESCRIPTIONEP2333050
DESCRIPTIONUS2003153082
DESCRIPTIONUS2005037493
DESCRIPTIONUS2005214939
DESCRIPTIONUS2008004287
DESCRIPTIONUS2008038820
DESCRIPTIONUS2008226558
DESCRIPTIONUS2008254003
DESCRIPTIONUS2009047739
DESCRIPTIONUS2010003757
DESCRIPTIONUS2010041054
DESCRIPTIONUS2010216181
DESCRIPTIONUS2010279403
DESCRIPTIONUS2011097799
DESCRIPTIONUS2011104125
DESCRIPTIONUS2013210141
DESCRIPTIONUS2013251694
DESCRIPTIONUS4683202
DESCRIPTIONUS4684611
DESCRIPTIONUS4952500
DESCRIPTIONUS5302523
DESCRIPTIONUS5322783
DESCRIPTIONUS5384253
DESCRIPTIONUS5464765
DESCRIPTIONUS5538877
DESCRIPTIONUS5538880
DESCRIPTIONUS5550318
DESCRIPTIONUS5563055
DESCRIPTIONUS5580859
DESCRIPTIONUS5589466
DESCRIPTIONUS5591616
DESCRIPTIONUS5610042
DESCRIPTIONUS5656610
DESCRIPTIONUS5702932
DESCRIPTIONUS5736524
DESCRIPTIONUS5780448
DESCRIPTIONUS5789215
DESCRIPTIONUS5925565
DESCRIPTIONUS5928906
DESCRIPTIONUS5935819
DESCRIPTIONUS5945100
DESCRIPTIONUS5981274
DESCRIPTIONUS5994624
DESCRIPTIONUS6280718
DESCRIPTIONUS6458589
DESCRIPTIONUS6506574
DESCRIPTIONUS6833269
DESCRIPTIONWO0181549
DESCRIPTIONWO03000868
DESCRIPTIONWO03006950
DESCRIPTIONWO03050249
DESCRIPTIONWO03050251
DESCRIPTIONWO2004007696
DESCRIPTIONWO2008006583
DESCRIPTIONWO2008094597
DESCRIPTIONWO9409699
DESCRIPTIONWO9506128
DESCRIPTIONWO9920741
OPPOSITIONWO2008124133
OPPOSITIONWO2009149233
OPPOSITIONWO2010027062
SEARCHEP2333050
SEARCHWO2010141801
SEARCHWO2012021632

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- HANNA ET AL., "Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency", CELL, (20080418), vol. 133, pages 250 - 264, XP002550844
INTERNATIONAL-SEARCH-REPORT- STAERK ET AL., "Reprogramming of human peripheral blood cells to induced pluripotent stem cells", CELL STEM CELL, (20100702), vol. 7, pages 20 - 24, XP055074654
INTERNATIONAL-SEARCH-REPORT- KAJI ET AL., "Virus free induction of pluripotency and subsequent excision of reprogramming factors", NATURE, (20090419), vol. 458, pages 771 - 775, XP002568858
INTERNATIONAL-SEARCH-REPORT- POLO ET AL., "Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells", NATURE BIOTECHNOLOGY, (20100719), vol. 28, no. 8, pages 848 - 857, XP055083375
INTERNATIONAL-SEARCH-REPORT- RAJESH ET AL., "Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells", BLOOD, (20110627), vol. 118, pages 1797 - 1800, XP055083379
INTERNATIONAL-SEARCH-REPORT- CHOI ET AL., "Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells", BLOOD, (20110531), vol. 118, pages 1801 - 1805, XP055083381
OPPOSITION- "General protocol for the immortalization of human B-lymphocytes using EBV", UNC Lineberger, (20070207), URL: http://unclineberger.org/research/core-facilities/tissueculture/b-lymphocytesprotocol, XP008136048-
OPPOSITION- "GM02254 LCL from B-Lymphocyte", Online excerpt of GM02254, URL: https://www.coriell.orq/0/Sections/Search/Sample Detail.aspx?Ref=GM02254&product= CC-
OPPOSITION- "GM22649 LCL from B-Lymphocyte", Online excerpt of GM22649, URL: https://www.coriell.orq/0/Sections/Search/Sample Detail.aspx?Ref=GM22649&product= CC-
OPPOSITION- MILLER, "Immortalization of Human Lymphocytes by Epstein-Barr Virus", The Yale Journal of Biology and Medicine, (19820000), vol. 55, pages 305 - 310, XP055482306-
OPPOSITION- HANNA et al., "Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency", NIH Public Access Author Manuscript, (20080000), pages 250 - 23, XP055482309
OPPOSITION- WADA et al., "Successful differentiation to T cells, but unsuccessful B-cell generation, from B-cell-derived induced pluripotent stem cells", International Immunology, (20100000), vol. 23, no. 1, pages 65 - 74, XP055063365
OPPOSITION- YU et al., "Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences", NIH Public Access Author Manuscript, (20090000), vol. 324, pages 1 - 9, XP055482312
OPPOSITION- RAJESH et al., "Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells", Blood, (20110627), vol. 118, no. 7, pages 1797 - 1800, XP055083379
OPPOSITION- CHOI et al., "Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells", Blood, (20110531), vol. 118, no. 7, pages 1801 - 1805, XP055083381
SEARCH- JOCHEN UTIKAL ET AL, "Immortalization eliminates a roadblock during cellular reprogramming into iPS cells", NATURE, (20090827), vol. 460, no. 7259, doi:10.1038/nature08285, ISSN 0028-0836, pages 1145 - 1148, XP055029395 [A] 1-15
SEARCH- ZHAOHUI YE ET AL, "Hematopoietic cells as sources for patient-specific iPSCs and disease modeling", CELL CYCLE, (20110901), vol. 10, no. 17, doi:10.4161/cc.10.17.17180, ISSN 1538-4101, pages 2840 - 2844, XP055092521 [XP] 1,4,5,7,14 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents